Evidence map›Paper›PMID 36371309›Full record

ArticleJournal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale2022

Comparison of passive versus active transcutaneous bone anchored hearing devices in the pediatric population.

Nael M Shoman, Usman Khan, Paul Hong

Open access · goldAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Letter to the Editor regarding "A comparative study of audiological outcomes and compliance between the Osia system and other bone conduction hearing implants" by Kim et al. European Archives of Otorhinolaryngology 2023 May; 280(5):2217-2224.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nael M ShomanDivision of Otolaryngology-Head and Neck Surgery, QEII Health Sciences Centre,, Dalhousie University, 3184 Dickson Building, 5820 University Avenue, Halifax, NS, B3H 2Y9, Canada. shoman@dal.ca.ORCID http://orcid.org/0000-0002-3367-0559
Usman KhanDivision of Otolaryngology-Head and Neck Surgery, QEII Health Sciences Centre,, Dalhousie University, 3184 Dickson Building, 5820 University Avenue, Halifax, NS, B3H 2Y9, Canada.
Paul HongDivision of Otolaryngology-Head and Neck Surgery, QEII Health Sciences Centre,, Dalhousie University, 3184 Dickson Building, 5820 University Avenue, Halifax, NS, B3H 2Y9, Canada.
Dalhousie University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTranscutaneous bone anchored hearing devices (BAHDs) were introduced in an effort to avoid potential complications associated with the abutment of percutaneous BAHDs. Transcutaneous BAHDs can be active or passive. While studies have demonstrated good outcomes with both, a direct comparison of audiological and clinical outcomes of these devices in the pediatric population has not yet been studied. STUDY

designRetrospective, multicenter study.

settingTwo tertiary academic centers.

methodsBetween 2015 and 2019, all patients who received an active transcutaneous BAHD (Bonebridge, BB) at one center, and patients that received a passive transcutaneous BAHD (Attract, AT) at another center, were included in this study. Exclusion criteria included age > 18 years, and mixed hearing loss or single-sided deafness. Study outcomes included patient demographics, indications, complications and preoperative and one-year postoperative audiometric data.

resultsEighteen BB and eight AT patients met the inclusion criteria. The age range was 5-16 years. There were no significant differences in complication outcomes. Both devices demonstrated similar mean improvements in hearing thresholds at frequencies of 250 Hz (38 dB Active vs. 38 dB Passive), 500 Hz (34 dB vs. 42 dB), 1000 Hz (34 dB vs. 40 dB) and 2000 Hz (31 dB vs. 22 dB). The BB was significantly more effective at frequencies of 4000 Hz (28 dB vs. 7 dB) and 8000 Hz (29 dB vs. 6 dB) (p < 0.05).

conclusionThis is the first study comparing audiological outcomes between an active and a passive transcutaneous BAHD in the pediatric population. While both devices improved audiometric outcomes in the low and mid frequencies, the active BAHD demonstrated significantly better outcomes in the higher frequencies.

Indexed as

Bone ConductionHearing AidsAdolescentAdultAminesChildChild, PreschoolDisulfidesHearingHearing Loss, ConductiveHumansMiddle AgedRetrospective StudiesTreatment OutcomeAminesbis(2-aminohexyl)disulfideDisulfidesActiveBone anchored hearing aidPassivePediatricTranscutaneous

Identifiers

PMID36371309
PMCPMC9652954
OpenAlexW4309073587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.